However, GPD1 KO increased the sensitivity of cancer cells to the antiproliferative effects of ETC inhibitors and suppressed xenograft tumor growth under ETC inhibition, indicating that GPD1 promoted tumor growth. The gene discussed is GPD1; the disease is neoplasm.